Olivier Loeillot, a Singapore-based executive at GE Healthcare Life Sciences, has been appointed general manager for the company’s commercial bioprocessing activities in Asia. In this newly-created role he will oversee services and technologies for the biopharmaceutical and vaccine manufacturing industries including helping companies improve product yields and reduce production times.
Mr Loeillot, who formerly worked at Lonza, earned a master’s degree in chemistry from the European High Institute of Chemistry in Strasbourg, France.
Copyright 2014 Evernow Publishing Ltd